Status:
COMPLETED
Reintervention-study After Previous Renal Denervation in Non-responding Patients With Severe Hypertension
Lead Sponsor:
Cardiovascular Center Frankfurt
Conditions:
Hypertension, Resistant to Conventional Therapy
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the effect of repeated renal denervation in non-responding patients with severe hypertension. Therefore ultrasound technique will be used.
Detailed Description
Renal Denervation is a CE-certified opportunity for treating patients with therapy-refractory hypertension. In some patients it doesn't show a significant lowering of the blood pressure, so a repeated...
Eligibility Criteria
Inclusion
- Individual is ≥18 years old
- Individual received renal denervation ≥12 months prior to study participation to no therapeutical avail and is scheduled for reintervention.
- Systolic Office based blood pressure ≥140mmHg
- Individual receives 3 or more antihypertensive drugs including one diuretic
- Individual is willing to provide written informed consent to participate in this study
Exclusion
- Individual has hypertension secondary to an identifiable and treatable cause
- Individual has any serious medical condition which in the opinion of the investigator may adversely affect the participation.
- Individual is pregnant, nursing or planning to be pregnant
- Renal artery abnormalities which may affect the procedure
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2016
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01834118
Start Date
June 1 2013
End Date
April 1 2016
Last Update
July 28 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CardioVascular Center Frankfurt
Frankfurt am Main, Hesse, Germany, 60389